- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2009
- Public Summary Document (PSD) July 2009 PBAC Meeting - PDF
Sunitinib malate – July 2009
Sunitinib malate, capsules, 12.5 mg (base), 25 mg (base) and 50 mg (base), Sutent®, July 2009
Last updated
30 October 2009
